Spray Dried Biologics For Pulmonary Dosage Forms

Join us for an insightful conversation on how spray drying is enabling the development of biologics for pulmonary delivery. This session will explore the science behind spray drying, its role in creating inhalable formulations, and the unique challenges and opportunities in this rapidly evolving space.

We’ll kick things off by looking at the fundamentals of pharmaceutical spray drying, how the process works, and why it’s so widely used in drug product development. From there, we’ll dive into pulmonary dosage forms, such as dry powder inhalers and soft mist formulations, and discuss what makes them ideal for certain biologics.

Next, we’ll explore the complexities of spray-drying biologics for inhalation. How do we maintain stability and ensure the right particle size for deep lung delivery? What hurdles do formulators face, and what strategies are emerging to overcome them? Finally, we’ll talk about testing and characterization, including how do we confirm that these spray-dried biologics are safe, effective, and ready for clinical use?